DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Sánchez-Garrido MA, Brandt SJ, Clemmensen C, Müller TD, DiMarchi RD, Tschöp MH.
GLP-1/glucagon receptor co-agonism for treatment of obesity.
Diabetologia 2017;
60 (10) 1851-1861
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.